C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape

[1]  M. Walker,et al.  KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy , 2018, Brain : a journal of neurology.

[2]  Edward T Chouchani,et al.  Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1 , 2018, Nature.

[3]  D. Harrison,et al.  Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2) , 2017, Cellular and molecular gastroenterology and hepatology.

[4]  J. Hiscott,et al.  Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  A. Levonen,et al.  Keap1 as the redox sensor of the antioxidant response. , 2017, Archives of biochemistry and biophysics.

[6]  A. Dinkova-Kostova,et al.  Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants☆ , 2017, Archives of biochemistry and biophysics.

[7]  K. Hashimoto,et al.  Antidepressant effects of TBE-31 and MCE-1, the novel Nrf2 activators, in an inflammation model of depression. , 2016, European journal of pharmacology.

[8]  I. Dulubova,et al.  Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding. , 2016, Biochimica et biophysica acta.

[9]  V. Zoete,et al.  Electron affinity of tricyclic, bicyclic, and monocyclic compounds containing cyanoenones correlates with their potency as inducers of a cytoprotective enzyme. , 2016, Bioorganic & medicinal chemistry letters.

[10]  A. Dinkova-Kostova,et al.  Loss of Nrf2 abrogates the protective effect of Keap1 downregulation in a preclinical model of cutaneous squamous cell carcinoma , 2016, Scientific Reports.

[11]  K. Nakayama,et al.  Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription , 2016, Nature Communications.

[12]  M. Fujita,et al.  In Situ Observation of Thiol Michael Addition to a Reversible Covalent Drug in a Crystalline Sponge. , 2016, Angewandte Chemie.

[13]  G. M. Di Guglielmo,et al.  The acetylenic tricyclic bis(cyano enone), TBE-31, targets microtubule dynamics and cell polarity in migrating cells. , 2016, Biochimica et biophysica acta.

[14]  Takafumi Suzuki,et al.  Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response , 2015, Molecular and Cellular Biology.

[15]  A. Dinkova-Kostova,et al.  Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action , 2015, Biochemical and biophysical research communications.

[16]  Masayuki Yamamoto,et al.  Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice , 2015, Molecular and Cellular Biology.

[17]  A. Dinkova-Kostova,et al.  New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase. , 2015, Journal of medicinal chemistry.

[18]  S. Ibbotson,et al.  Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans , 2015, Cancer Prevention Research.

[19]  P. Rada,et al.  The PTEN/NRF2 axis promotes human carcinogenesis. , 2014, Antioxidants & redox signaling.

[20]  J. Yon,et al.  Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO , 2014, PloS one.

[21]  A. Cuadrado,et al.  Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation* , 2014, The Journal of Biological Chemistry.

[22]  J. Hayes,et al.  The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. , 2014, Trends in biochemical sciences.

[23]  Takafumi Suzuki,et al.  Toward clinical application of the Keap1-Nrf2 pathway. , 2013, Trends in pharmacological sciences.

[24]  A. Cuadrado,et al.  Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. , 2012, Oncogene.

[25]  Takafumi Suzuki,et al.  Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. , 2012, Free radical biology & medicine.

[26]  P. Rada,et al.  Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis , 2012, Molecular and Cellular Biology.

[27]  J. Bliska,et al.  Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents. , 2012, Journal of medicinal chemistry.

[28]  Y. Surh,et al.  Guggulsterone induces heme oxygenase-1 expression through activation of Nrf2 in human mammary epithelial cells: PTEN as a putative target. , 2012, Carcinogenesis.

[29]  M. Sporn,et al.  Proteomic Analysis Shows Synthetic Oleanane Triterpenoid Binds to mTOR , 2011, PloS one.

[30]  M. Lajoie,et al.  Tricyclic compounds containing nonenolizable cyano enones. A novel class of highly potent anti-inflammatory and cytoprotective agents. , 2011, Journal of medicinal chemistry.

[31]  P. Rada,et al.  SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner , 2011, Molecular and Cellular Biology.

[32]  M. McMahon,et al.  Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals , 2010, Proceedings of the National Academy of Sciences.

[33]  A. Dinkova-Kostova,et al.  NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. , 2010, Archives of biochemistry and biophysics.

[34]  Ying Zhang,et al.  An Exceptionally Potent Inducer of Cytoprotective Enzymes , 2010, The Journal of Biological Chemistry.

[35]  J. Hayes,et al.  Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. , 2010, Free radical biology & medicine.

[36]  M. Sporn,et al.  Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN. , 2009, Investigative ophthalmology & visual science.

[37]  A. Kong,et al.  Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. , 2008, Biochemical pharmacology.

[38]  A. Dinkova-Kostova,et al.  Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles , 2008, Proceedings of the National Academy of Sciences.

[39]  M. Sporn,et al.  A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin. , 2008, Cancer research.

[40]  Takafumi Suzuki,et al.  Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity , 2008, Molecular and Cellular Biology.

[41]  M. Sporn,et al.  Novel tricyclic compounds having acetylene groups at C-8a and cyano enones in rings A and C: highly potent anti-inflammatory and cytoprotective agents. , 2007, Journal of Medicinal Chemistry.

[42]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[43]  Masayuki Yamamoto,et al.  Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. , 2006, The Journal of clinical investigation.

[44]  Paul Talalay,et al.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[46]  R. Tyrrell,et al.  Regulation of heme oxygenase-1 gene transcription: recent advances and highlights from the International Conference (Uppsala, 2003) on Heme Oxygenase. , 2004, Antioxidants & redox signaling.

[47]  J. Harper,et al.  The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.

[48]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[49]  J. Morrow,et al.  Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. , 2004, The Biochemical journal.

[50]  Paul Talalay,et al.  Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Mark Hannink,et al.  Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress , 2003, Molecular and Cellular Biology.

[52]  M. Sporn,et al.  Design and Synthesis of Tricyclic Compounds with Enone Functionalities in Ring A and C: A Novel Class of Highly Active Inhibitors of Nitric Oxide Production in Mouse Macrophages , 2003 .

[53]  M. Sporn,et al.  Design and synthesis of tricyclic compounds with enone functionalities in rings A and C: a novel class of highly active inhibitors of nitric oxide production in mouse macrophages. , 2002, Journal of medicinal chemistry.

[54]  R. Cole,et al.  Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Sporn,et al.  A novel dicyanotriterpenoid, 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-onitrile, active at picomolar concentrations for inhibition of nitric oxide production. , 2002, Bioorganic & medicinal chemistry letters.

[56]  M. Sporn,et al.  Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages. , 2000, Journal of medicinal chemistry.

[57]  M. Sporn,et al.  A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. , 1999, Cancer research.

[58]  J. D. Engel,et al.  Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. , 1999, Genes & development.

[59]  M. Sporn,et al.  Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages. , 1998, Bioorganic & medicinal chemistry letters.

[60]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[61]  S. R. Spencer,et al.  The electrophile counterattack response: protection against neoplasia and toxicity. , 1993, Advances in enzyme regulation.

[62]  P. Talalay,et al.  Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Santamaria,et al.  Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. , 1988, Analytical biochemistry.